Gateway Investment Advisers’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$822K Sell
34,156
-56,589
-62% -$1.48M 0.01% 479
2026
Q1
$2.55M Buy
90,745
+23,767
+35% +$633K 0.03% 217
2025
Q4
$1.67M Buy
66,978
+8,147
+14% +$205K 0.02% 315
2025
Q3
$1.5M Sell
58,831
-1,063,800
-95% -$26.3M 0.01% 301
2025
Q2
$27.2M Buy
1,122,631
+66,491
+6% +$1.55M 0.3% 79
2025
Q1
$26.8M Sell
1,056,140
-86,468
-8% -$2.26M 0.31% 77
2024
Q4
$30.3M Sell
1,142,608
-58,160
-5% -$1.58M 0.34% 72
2024
Q3
$34.8M Sell
1,200,768
-69,368
-5% -$2.02M 0.38% 66
2024
Q2
$35.5M Sell
1,270,136
-85,771
-6% -$2.36M 0.4% 60
2024
Q1
$37.6M Sell
1,355,907
-6,180
-0.5% -$171K 0.43% 61
2023
Q4
$39.2M Sell
1,362,087
-52,604
-4% -$1.59M 0.46% 59
2023
Q3
$46.9M Sell
1,414,691
-53,005
-4% -$1.87M 0.59% 40
2023
Q2
$53.8M Sell
1,467,696
-55,977
-4% -$2.18M 0.63% 38
2023
Q1
$62.2M Sell
1,523,673
-15,683
-1% -$677K 0.76% 29
2022
Q4
$78.9M Sell
1,539,356
-66,582
-4% -$3.19M 0.97% 20
2022
Q3
$70.3M Sell
1,605,938
-136,362
-8% -$6.63M 0.88% 22
2022
Q2
$91.3M Buy
1,742,300
+43,091
+3% +$2.2M 1.03% 17
2022
Q1
$88M Buy
1,699,209
+27,910
+2% +$1.45M 0.87% 20
2021
Q4
$98.7M Sell
1,671,299
-69,474
-4% -$3.44M 0.94% 19
2021
Q3
$74.9M Buy
1,740,773
+1,785
+0.1% +$79.1K 0.78% 26
2021
Q2
$68.1M Sell
1,738,988
-10,602
-0.6% -$412K 0.7% 31
2021
Q1
$63.4M Sell
1,749,590
-68,093
-4% -$2.42M 0.69% 32
2020
Q4
$66.9M Sell
1,817,683
-310,612
-15% -$11.4M 0.73% 33
2020
Q3
$74.1M Sell
2,128,295
-24,222
-1% -$849K 0.86% 29
2020
Q2
$66.8M Sell
2,152,517
-390,138
-15% -$13.3M 0.79% 32
2020
Q1
$78.7M Buy
2,542,655
+21,112
+0.8% +$719K 0.97% 24
2019
Q4
$93.7M Sell
2,521,543
-81,153
-3% -$2.89M 0.93% 25
2019
Q3
$88.7M Sell
2,602,696
-341,164
-12% -$12.4M 0.89% 30
2019
Q2
$121M Sell
2,943,860
-134,371
-4% -$5.34M 1.09% 18
2019
Q1
$124M Sell
3,078,231
-66,912
-2% -$2.68M 1.1% 19
2018
Q4
$130M Buy
3,145,143
+18,816
+0.6% +$781K 1.23% 14
2018
Q3
$131M Sell
3,126,327
-40,788
-1% -$1.57M 1.1% 15
2018
Q2
$109M Sell
3,167,115
-167,280
-5% -$5.72M 0.96% 22
2018
Q1
$112M Sell
3,334,395
-21,637
-0.6% -$744K 1% 19
2017
Q4
$115M Sell
3,356,032
-34,292
-1% -$1.17M 0.98% 22
2017
Q3
$115M Buy
3,390,324
+43,472
+1% +$1.4M 0.99% 22
2017
Q2
$107M Sell
3,346,852
-69,762
-2% -$2.2M 0.96% 23
2017
Q1
$111M Sell
3,416,614
-76,628
-2% -$2.42M 1.02% 20
2016
Q4
$108M Sell
3,493,242
-385,464
-10% -$11.8M 1.01% 21
2016
Q3
$125M Sell
3,878,706
-259,282
-6% -$8.67M 1.11% 16
2016
Q2
$138M Sell
4,137,988
-193,765
-4% -$6.18M 1.19% 16
2016
Q1
$122M Sell
4,331,753
-108,805
-2% -$3.11M 1.06% 19
2015
Q4
$136M Buy
4,440,558
+23,599
+0.5% +$742K 1.14% 14
2015
Q3
$132M Sell
4,416,959
-86,464
-2% -$2.77M 1.17% 13
2015
Q2
$143M Sell
4,503,423
-23,504
-0.5% -$766K 1.19% 12
2015
Q1
$149M Sell
4,526,927
-6,813
-0.2% -$217K 1.24% 9
2014
Q4
$134M Sell
4,533,740
-669,208
-13% -$19.2M 1.11% 13
2014
Q3
$146M Sell
5,202,948
-324,447
-6% -$9.11M 1.15% 14
2014
Q2
$156M Sell
5,527,395
-196,286
-3% -$5.6M 1.22% 10
2014
Q1
$174M Sell
5,723,681
-63,753
-1% -$1.9M 1.42% 10
2013
Q4
$168M Sell
5,787,434
-390,969
-6% -$11.4M 1.35% 10
2013
Q3
$168M Sell
6,178,403
-256,690
-4% -$6.98M 1.43% 9
2013
Q2
$171M Buy
+6,435,093
New +$178M 1.49% 10

Other funds holding PFE

Gateway Investment Advisers's PFE Position: Q2 2026 in Review

Gateway Investment Advisers reduced its Pfizer (PFE) stake by 62% in Q2 2026, selling an estimated $1.48M and leaving 34,156 shares worth $822K. The position accounts for 0.01% of the portfolio, ranked #479.

Gateway Investment Advisers first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $174M in Q1 2014. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Gateway Investment Advisers held 34,156 shares of Pfizer worth $822K as of Q2 2026.
  • Gateway Investment Advisers sold 56,589 Pfizer shares in Q2 2026, an estimated $1.48M.
  • Pfizer made up 0.01% of Gateway Investment Advisers's portfolio in Q2 2026, its #479 holding.
  • Gateway Investment Advisers first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Gateway Investment Advisers's Pfizer position peaked at $174M in Q1 2014.
  • 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Gateway Investment Advisers's 13F filing for Q2 2026, filed 20 Jul 2026.